Feasibility of autologous stem cell transplant followed by reduced intensity allogeneic stem cell transplantation for high risk neuroblastoma: A single institution pilot study

被引：0
|
作者：
Yalizasbiro, D. J. [1 ]
Lee, A. [1 ]
Bhatia, M. [1 ]
Glade-Bender, J. [1 ]
Qualter, E. [1 ]
Militano, O. [1 ]
Harrison, L. A. [1 ]
Davenport, V. [1 ]
Cheung, K. [1 ]
Bradley, M. B. [1 ]
Garvin, J. H. [1 ]
Del Toro, G. [1 ]
Cairo, M. S. [1 ]
机构：
[1] Columbia Univ, New York, NY USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2007年 / 13卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
185
引用
收藏
页码：68 / 69
页数：2
相关论文
共 50 条
  • [1] A multicenter comparison of autologous stem cell transplantation followed by reduced-intensity allogeneic stem cell transplantation with tandem autologous stem cell transplantation in multiple myeloma
    Min, Chang-Ki
    Kim, Hwak
    Kim, Kihyun
    Kwak, Jae-Yong
    Lee, Seung Tare
    Won, Jong Ho
    Yoon, Sung-Soo
    Lee, Jae Hoon
    Suh, Cheol Won
    BLOOD, 2007, 110 (11) : 286A - 286A
  • [2] Reduced-Intensity Allogeneic Stem Cell Transplantation for Children With Neuroblastoma Who Failed Tandem Autologous Stem Cell Transplantation
    Sung, Ki Woong
    Park, Jun Eun
    Chueh, Hee Won
    Lee, Soo Hyun
    Yoo, Keon Hee
    Koo, Hong Hoe
    Kim, Ju Youn
    Cho, Eun Joo
    PEDIATRIC BLOOD & CANCER, 2011, 57 (04) : 660 - 665
  • [3] Reduced-Intensity Unmanipulated Haploidentical Stem Cell Transplantation for Relapsed High-Risk Neuroblastoma After Autologous Stem Cell Transplantation
    Rostami, Tahereh
    Kiumarsi, Azadeh
    Hedayatiasl, Amir Abbas
    Mousavi, Seied Asadollah
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 214 - 215
  • [4] Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis
    Kroeger, N
    Zabelina, T
    Schieder, H
    Panse, J
    Ayuk, F
    Fehse, N
    Fehse, B
    Waschke, O
    Kvasnicka, HM
    Thiele, J
    Zander, A
    BLOOD, 2004, 104 (11) : 423A - 423A
  • [5] Reduced intensity allogeneic stem cell transplantation for patients who have failed a prior autologous stem cell transplant.
    Cohen, S
    Fung, H
    Stein, A
    Nademanee, A
    Rodriguez, R
    O'Donnell, M
    Parker, P
    Molina, A
    Margolin, K
    Somlo, G
    Sahebi, F
    Spielberger, R
    Snyder, D
    Krishnan, A
    Popplewell, L
    Falk, P
    Kogut, N
    Smith, D
    Forman, SJ
    BLOOD, 2002, 100 (11) : 177A - 177A
  • [6] Reduced-Intensity Allogeneic Stem Cell Transplant for Sickle Cell Disease in Pediatrics: A Single Institution Experience
    Eckrich, Michael J.
    Madden, Lisa
    Taylor, Candace
    Matheny, Christina
    Frausto-Garcia, Erica
    Chan, Ka Wah
    Quigg, Troy C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S407 - S408
  • [7] Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma
    Chen, Yi-Bin
    Li, Shuli
    Fisher, David C.
    Driscoll, Jessica
    Del Rio, Candice
    Abramson, Jeremy
    Armand, Philippe
    Barnes, Jeffrey
    Brown, Jennifer
    Cutler, Corey
    El-Jawahri, Areej
    Ho, Vincent T.
    Hochberg, Ephraim
    McAfee, Steven
    Takvorian, Ronald
    Spitzer, Thomas R.
    Antin, Joseph H.
    Soiffer, Robert
    Jacobsen, Eric
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (09) : 1583 - 1588
  • [8] Reduced-intensity conditioning allogeneic stem cell transplantation for high-risk neuroblastoma: French experience
    Paillard, C.
    Lutz, P.
    Tchirkov, A.
    Cojean, N.
    David, A.
    Dore, E.
    Isfan, F.
    Merlin, E.
    Marabelle, A.
    Rousseau, R.
    Demeocq, F.
    Kanold, J.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S154 - S154
  • [9] High-dose chemotherapy with autologous or allogeneic hematopoietic stem cell transplantation for high-risk neuroblastoma patients, a single transplant center experience
    Kazantsev, Ilya
    Gevorgian, Asmik
    Iukhta, Tatiana
    Tolkunova, Polina
    Kozlov, Andrew
    Andreeva, Tatiana
    Morozova, Elena
    Litvinov, Andrey
    Kuga, Polina
    Safonova, Svetlana
    Punanov, Yuri
    Zubarovskaya, Liudmila
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2019, 54 : 558 - 559
  • [10] Phase II Trial of Busulfan-Based Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed By Reduced Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma
    Chen, Yi-Bin
    Li, Shuli
    Del Rio, Candice
    Driscoll, Jessica
    Sadrzadeh, Hossein
    Abramson, Jeremy S.
    Armand, Philippe
    Barnes, Jeffrey
    Cutler, Corey S.
    Fisher, David C.
    Ho, Vincent T.
    Hochberg, Ephraim
    McAfee, Steven L.
    Takvorian, Ronald
    Antin, Joseph H.
    Soiffer, Robert J.
    Jacobsen, Eric
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S73 - S73
12345